Johnson & Johnson aiming to produce 1 billion coronavirus vaccine in 2021

Posted at 2:43 PM, May 10, 2020
and last updated 2020-05-10 15:43:27-04

Health care giant Johnson & Johnson says they are looking to produce a billion coronavirus vaccines next year, according to the company's Chief Scientific Officer.

Dr. Paul Stoffels told ABC News the company is upscaling manufacturing and will start producing the vaccine later this year.

"We are preparing clinical trials. We are fully and upscaling. We start clinical trials in September and hope to have data by the end of the year. As well as now working toward one billion vaccines for next year," said Dr. Stoffels "We will have some vaccine available this year, but it will depend on the authorities - the FDA and others - to decide whether it can be used earlier, before efficacy data are available."

Johnson & Johnson says it has been working on a vaccine since January.

The company is partnering with the Biomedical Advance Research and Development Authority, a division of the Department of Health and Human Services.